Oct 14, 2013

Farmak’s portfolio has added the antifungal drug Lamicon Dermgel

Farmak, the leader in the domestic pharmaceutical market, has expanded the Lamicon antifungal line with a new drug product, Lamicon Dermgel. The new drug is produced in the form of a gel (15 g).

Lamicon Dermgel is an antifungal agent in the form of a gel with a broad spectrum of action and a short course of treatment. It helps to eliminate one of the major symptoms of fungal skin infection – itching.

The drug is recommended for the treatment of skin infections caused by dermatophytes (tinea corporis, tinea cruris, tinea pedis) and tinea versicolor.

The main feature of the new drug is its cooling effect and antipruritic action.

Now the Lamicon antifungal portfolio has three dosage forms for topical use: Lamicon cream, Lamicon spray, Lamicon Dermgel, and also Lamicon in tablet form.

Back to the News